You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Chem., 18 November 2022

Sec. Medicinal and Pharmaceutical Chemistry

Volume 10 - 2022 | https://doi.org/10.3389/fchem.2022.1082236

Corrigendum: Dual-specificity phosphatase CDC25B was inhibited by natural product HB-21 through covalently binding to the active site

  • 1. State Key Laboratory of Plateau Ecology and Agriculture, Qinghai University, Xining, China

  • 2. Department of Pharmacy, Medical College of Qinghai University, Xining, China

Article metrics

View details

1,3k

Views

400

Downloads

In the original article, there was an error in the affiliations as published, in which a third affiliation was wrongly included for author “Shoude Zhang”. The correct affiliations appear above.

In the original article, there was an error in Figure 6, page 4, as published. In the same batch of experiments, WB experiments for two compounds were done at the same time, and the article incorrectly used the results of another drug in the experiments. The corrected Figure 6 and its caption appear below.

FIGURE 6

FIGURE 6

Inhibition of CDK1 dephosphorylation caused by HB-21. The cells in the G2/M phase were treated with the indicated concentration of HB-21 or DMSO for 4 h, and then harvested. The samples were processed for Western blot analysis.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

Cdc25B inhibitor, sesquiterpene lactone, anticancer, cell cycle progression, covalent binding to protein

Citation

Zhang S, Jia Q, Gao Q, Fan X, Weng Y and Su Z (2022) Corrigendum: Dual-specificity phosphatase CDC25B was inhibited by natural product HB-21 through covalently binding to the active site. Front. Chem. 10:1082236. doi: 10.3389/fchem.2022.1082236

Received

31 October 2022

Accepted

10 November 2022

Published

18 November 2022

Volume

10 - 2022

Edited and reviewed by

Michael Kassiou, The University of Sydney, Australia

Updates

Copyright

*Correspondence: Shoude Zhang, ; Zhanhai Su,

This article was submitted to Medicinal and Pharmaceutical Chemistry, a section of the journal Frontiers in Chemistry

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics